Advertisement
Screener

VivoSim Labs, Inc. (VIVS) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value

1.8 / 5 stars · 31/86 Roast Me

VivoSim Labs, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value

VivoSim Labs, Inc. (VIVS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $0 for the 9-month period ending 2025-12-31, per its 10-Q filed 2026-02-11.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-02-11

  • VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-12-31 was $0.00.
  • VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-09-30 was $0.00.
  • VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-06-30 was $0.00.
  • VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2024-12-31 was $0.00.
  • VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $0.00.
  • VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $0.00.
  • VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2021 was $0.00.
  • VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month
2025-12-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-11
$0.00
derived: sum of 2 quarters · filed 2026-02-11
$0.00
10-Q · filed 2026-02-11
2025-09-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06
$0.00
10-Q · filed 2025-11-06
2025-06-30$0.00
10-Q · filed 2025-08-12
2024-12-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-19
$0.00
10-Q · filed 2025-02-19
2024-09-30$0.00
10-Q · filed 2024-11-08
2024-03-31$0.00
10-Q · filed 2024-08-05
2023-06-30$0.00
10-Q · filed 2023-08-10
$0.00
derived: sum of 2 quarters · filed 2023-08-10
$0.00
derived: sum of 3 quarters · filed 2023-08-10
$0.00
derived: sum of 4 quarters · filed 2023-08-10
2023-03-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-14
$0.00
derived: sum of 2 quarters · filed 2023-07-14
$0.00
derived: sum of 3 quarters · filed 2023-07-14
$0.00
10-K · filed 2023-07-14
2022-12-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-09
$0.00
derived: sum of 2 quarters · filed 2023-02-09
$0.00
10-Q · filed 2023-02-09
$0.00
derived: sum of 4 quarters · filed 2023-02-09
2022-09-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-10
$0.00
10-Q · filed 2022-11-10
$0.00
derived: sum of 3 quarters · filed 2022-11-10
$0.00
derived: sum of 4 quarters · filed 2022-11-10
2022-06-30$0.00
10-Q · filed 2022-08-11
$0.00
derived: sum of 2 quarters · filed 2022-08-11
$0.00
derived: sum of 3 quarters · filed 2022-08-11
$0.00
derived: sum of 4 quarters · filed 2022-08-11
2022-03-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-10
$0.00
derived: sum of 2 quarters · filed 2022-06-10
$0.00
derived: sum of 3 quarters · filed 2022-06-10
$0.00
10-K · filed 2022-06-10
2021-12-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-14
$0.00
derived: sum of 2 quarters · filed 2022-02-14
$0.00
10-Q · filed 2022-02-14
-$22.46K
derived: sum of 4 quarters · filed 2022-02-14
2021-09-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-08
$0.00
10-Q · filed 2021-11-08
-$22.46K
derived: sum of 3 quarters · filed 2021-11-08
-$8.58K
derived: sum of 4 quarters · filed 2021-11-08
2021-06-30$0.00
10-Q · filed 2021-08-06
-$22.46K
derived: sum of 2 quarters · filed 2021-08-06
-$8.58K
derived: sum of 3 quarters · filed 2021-08-06
$0.00
derived: sum of 4 quarters · filed 2021-08-06
2021-03-31-$22.46K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-15
-$8.58K
derived: sum of 2 quarters · filed 2021-06-15
$0.00
derived: sum of 3 quarters · filed 2021-06-15
$0.00
10-K · filed 2021-06-15
2020-12-31$13.88K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-08
$22.46K
derived: sum of 2 quarters · filed 2021-02-08
$22.46K
10-Q · filed 2021-02-08
$22.46K
derived: sum of 4 quarters · filed 2021-02-08
2020-09-30$8.58K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-05
$8.58K
10-Q · filed 2020-11-05
$8.58K
derived: sum of 3 quarters · filed 2020-11-05
$8.58K
derived: sum of 4 quarters · filed 2020-11-05
2020-06-30$0.00
10-Q · filed 2020-08-10
$0.00
derived: sum of 2 quarters · filed 2020-08-10
$0.00
derived: sum of 3 quarters · filed 2020-08-10
$0.00
derived: sum of 4 quarters · filed 2020-08-10
2020-03-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-28
$0.00
derived: sum of 2 quarters · filed 2020-05-28
$0.00
derived: sum of 3 quarters · filed 2020-05-28
$0.00
10-K · filed 2020-05-28
2019-12-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10
$0.00
derived: sum of 2 quarters · filed 2020-02-10
$0.00
10-Q · filed 2020-02-10
$0.00
derived: sum of 4 quarters · filed 2020-02-10
2019-09-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-07
$0.00
10-Q · filed 2019-11-07
$0.00
derived: sum of 3 quarters · filed 2019-11-07
2019-06-30$0.00
10-Q · filed 2019-08-08
$0.00
derived: sum of 2 quarters · filed 2019-08-08
2019-03-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-03
$561.59K
10-K · filed 2019-06-03
2018-12-31$561.59K
10-Q · filed 2019-02-07
2018-03-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-31
$0.00
derived: sum of 2 quarters · filed 2018-05-31
$235.00K
derived: sum of 3 quarters · filed 2018-05-31
$235.00K
10-K · filed 2018-05-31
2017-12-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-08
$235.00K
derived: sum of 2 quarters · filed 2018-02-08
$235.00K
10-Q · filed 2018-02-08
$235.00K
derived: sum of 4 quarters · filed 2018-02-08
2017-09-30$235.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-09
$235.00K
10-Q · filed 2017-11-09
$235.00K
derived: sum of 3 quarters · filed 2017-11-09
$262.93K
derived: sum of 4 quarters · filed 2017-11-09
2017-06-30$0.00
10-Q · filed 2017-08-09
$0.00
derived: sum of 2 quarters · filed 2017-08-09
$27.93K
derived: sum of 3 quarters · filed 2017-08-09
$356.62K
derived: sum of 4 quarters · filed 2017-08-09
2017-03-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-07
$27.93K
derived: sum of 2 quarters · filed 2017-06-07
$356.62K
derived: sum of 3 quarters · filed 2017-06-07
$356.62K
10-K · filed 2017-06-07
2016-12-31$27.93K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-09
$356.62K
derived: sum of 2 quarters · filed 2017-02-09
$356.62K
10-Q · filed 2017-02-09
$356.62K
derived: sum of 4 quarters · filed 2017-02-09
2016-09-30$328.69K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-03
$328.69K
10-Q · filed 2016-11-03
$328.69K
derived: sum of 3 quarters · filed 2016-11-03
$376.65K
derived: sum of 4 quarters · filed 2016-11-03
2016-06-30$0.00
10-Q · filed 2016-08-04
$0.00
derived: sum of 2 quarters · filed 2016-08-04
$47.96K
derived: sum of 3 quarters · filed 2016-08-04
$50.96K
derived: sum of 4 quarters · filed 2016-08-04
2016-03-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-09
$47.96K
derived: sum of 2 quarters · filed 2016-06-09
$50.96K
derived: sum of 3 quarters · filed 2016-06-09
$112.44K
10-K · filed 2016-06-09
2015-12-31$47.96K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-08
$50.96K
derived: sum of 2 quarters · filed 2016-02-08
$112.44K
10-Q · filed 2016-02-08
$533.29K
derived: sum of 4 quarters · filed 2016-06-09
2015-09-30$2.99K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-09
$64.48K
10-Q · filed 2015-11-09
$485.32K
derived: sum of 3 quarters · filed 2016-06-09
$523.12K
derived: sum of 4 quarters · filed 2016-06-09
2015-06-30$61.48K
10-Q · filed 2015-08-10
$482.33K
derived: sum of 2 quarters · filed 2016-06-09
$520.12K
derived: sum of 3 quarters · filed 2016-06-09
$666.00K
derived: sum of 4 quarters · filed 2016-06-09
2015-03-31$420.85K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-09
$458.64K
derived: sum of 2 quarters · filed 2016-06-09
$604.51K
derived: sum of 3 quarters · filed 2016-06-09
$883.79K
10-K · filed 2016-06-09
2014-12-31$37.79K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-06
$183.66K
derived: sum of 2 quarters · filed 2015-02-06
$462.95K
10-Q · filed 2015-02-06
$732.85K
derived: sum of 4 quarters · filed 2015-06-09
2014-09-30$145.87K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-07
$425.16K
10-Q · filed 2014-11-07
$695.05K
derived: sum of 3 quarters · filed 2015-06-09
$1.41M
derived: sum of 4 quarters · filed 2015-06-09
2014-06-30$279.28K
10-Q · filed 2014-08-08
$549.18K
derived: sum of 2 quarters · filed 2015-06-09
$1.26M
derived: sum of 3 quarters · filed 2015-06-09
2014-03-31$269.90K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-09
$980.23K
derived: sum of 2 quarters · filed 2015-06-09
$1.00M
10-K · filed 2015-06-09
2013-12-31$710.33K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-06
$732.52K
10-Q · filed 2014-02-06
2013-09-30$22.19K
10-Q · filed 2013-11-08
2012-12-31$564.64K
10-K · filed 2014-06-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CURIS INC (CRIS)United States$0.002B-0.05
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
Silexion Therapeutics Corp (SLXN)$0.001B
AIM ImmunoTech Inc. (AIM)United States$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70